IP Library Granted Patent US 9,115,170
Granted Patent B2
US 9,115,170 · App. 13/754,105 · Granted Aug 25, 2015

Methods and compositions related to internalizing RGD peptides

Inventors: Erkki Ruoslahti (Buellton, CA); Kazuki Sugahara (Goleta, CA); Tambet Teesalu (Goleta, CA)
Assignee: Sanford-Burnham Medical Research Institute
C07K7/06A61K47/48246A61K49/0002A61K49/0043A61K49/0056A61K49/0082A61K51/082C07K5/081C07K5/1013C07K5/1019C07K7/64
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,115,170
App. No.
13/754,105
Granted
Aug 25, 2015
Kind
B2
Abstract

Disclosed are compositions and methods useful for targeting tissue undergoing angiogenesis or to cells or tissue expressing αv integrins. The compositions and methods are based on peptide sequences that selectively bind to and home to tissue undergoing angiogenesis or to cells or tissue expressing αv integrins in animals. The disclosed targeting is useful for delivering therapeutic and detectable agents to tissue experiencing angiogenesis or to cells or tissue expressing αv integrins.

Claims (16)

1. An isolated peptide comprising an amino acid segment comprising the amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO:290, one of the amino acid sequences CRGD(R/K/H)GV(D/E/H)C (SEQ ID NO:329), or one of the amino acid sequences CRGDHGP(D/E/H)C (SEQ ID NO:330) consisting of one, two, or three conservative amino acid substitutions.

2. The isolated peptide of claim 1 , wherein the peptide has a length of less than 100 residues.

3. The isolated peptide of claim 1 , wherein the peptide has a length of less than 50 residues.

4. The isolated peptide of claim 1 , wherein the peptide has a length of less than 20 residues.

5. The isolated peptide of claim 1 , wherein the amino acid segment is cyclic.

6. The isolated peptide of claim 5 , wherein the amino acid segment is cyclized via a disulfide bond.

7. The isolated peptide of claim 1 , wherein the peptide selectively homes to a site of angiogenesis.

8. The isolated peptide of claim 7 , wherein the angiogenesis is at a site of injury.

9. The isolated peptide of claim 7 , wherein the angiogenesis is at a surgical site.

10. The isolated peptide of claim 1 , wherein the peptide selectively homes to a tumor.

11. The isolated peptide of claim 1 , wherein the peptide selectively homes to a site of arthritis.

12. The isolated peptide of claim 1 , wherein the peptide selectively homes to a cell or tissue expressing one or more αv integrins.

13. The isolated peptide of claim 1 , wherein the peptide selectively homes to a cell or tissue expressing one or more av integrins and neuropilin-1.

14. The isolated peptide of claim 1 , wherein the peptide consists of the amino acid segment.

15. The isolated peptide of claim 1 , wherein the peptide consists of the amino acid sequence.

16. An isolated peptide comprising an amino acid segment comprising the amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO:290, one of the amino acid sequences CRGD(R/K/H)GV(D/E/H)C (SEQ ID NO:329), or one of the amino acid sequences CRGDHGP(D/E/H)C (SEQ ID NO:330) consisting of one, two, or three conservative amino acid substitutions, wherein the amino acid sequence comprises RGD.

Assignments (3)
CHANGE OF NAME Recorded Oct 8, 2020
From: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
To: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Reel/Frame 054033/0296 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2013
From: RUOSLAHTI, ERKKI; TEESALU, TAMBET; SUGAHARA, KAZUKI
To: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
Reel/Frame 029723/0962 →
CHANGE OF NAME Recorded Jan 30, 2013
From: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
To: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
Reel/Frame 029724/0068 →
Continuity (3)
Continuation 12355672 · Jan 16, 2009
Provisional Application 61022131 · Jan 18, 2008
Related Publication 20130343989A1 · Dec 26, 2013